Ketanserin attenuates nicotine-induced working memory improvement in rats

Pharmacology Biochemistry and Behavior

Volumn 82, Issue 2, 2005, Pages 289-292

  Levin, Edward ^a   Icenogle, Laura ^a   Farzad, Ashkan ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Ketanserin; Nicotine; Radial arm maze; Working memory

Indexed keywords

KETANSERIN; NICOTINE TARTRATE; SEROTONIN 2 ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; ATTENTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; TASK PERFORMANCE; TRAINING; WORKING MEMORY;

ANIMALS; DRUG INTERACTIONS; FEMALE; KETANSERIN; MAZE LEARNING; MEMORY, SHORT-TERM; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN, 5-HT2; SEROTONIN ANTAGONISTS;

ANIMALIA;

EID: 28444476679     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.08.017     Document Type: Article

References (21)

1. N. Addy, and E.D. Levin Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats Neuropsychopharmacology 27 2002 534 541
2. L.E. Adler, L.D. Hoffer, A. Wiser, and R. Freedman Normalization of auditory physiology by cigarette smoking in schizophrenic patients Am J Psychiatry 150 1993 1856 1861
3. J.E. Aldridge, E.D. Levin, F.J. Seidler, and T.A. Slotkin Developmental exposure to chlorpyrifos elicits behavioral alterations resembling animal models of depression and involving serotonergic mechanisms Environ Health Perspect 113 2005 527 531
4. J. Court, D. Spurden, S. Lloyd, I. McKeith, C. Ballard, and N. Cairns Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus J Neurochem 73 1999 1590 1597
5. J. de Leon, M. Dadvand, C. Canuso, A.O. White, J.K. Stanilla, and G.M. Simpson Schizophrenia and smoking: an epidemiological survey in a state hospital Am J Psychiatry 152 1995 453 455
6. J.R. Hughes, D.K. Hatsukami, J.E. Mitchell, and L.A. Dahlgren Prevalence of smoking among psychiatric outpatients Am J Psychiatry 143 1986 993 997
7. C. Kelly, and R. McCreadie Cigarette smoking and schizophrenia Adv Psychiatr Treat 6 2000 327 331
8. E.D. Levin, W. Wilson, J.E. Rose, and J. McEvoy Nicotine-haloperidol interactions and cognitive performance in schizophrenics Neuropsychopharmacology 15 1996 429 436
9. E.D. Levin, and B.B. Simon Nicotinic acetylcholine involvement in cognitive function in animals Psychopharmacology 138 1998 217 230
10. E.D. Levin, and A.H. Rezvani Development of nicotinic drug therapy for cognitive disorders Eur J Pharmacology 393 2000 141 146
11. S. Matsubara, R. Matsubara, I. Kusumi, T. Koyama, and I. Yamashita Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo J Pharmacol Exp Ther 265 1993 498 508
12. P.A. Newhouse, A. Potter, and E.D. Levin Nicotinic system involvement in Alzheimer's and Parkinson's diseases: implications for therapeutics Drugs Aging 11 1997 206 228
13. A.H. Rezvani, and E.D. Levin Cognitive effects of nicotine Biol Psychiatry 49 2001 258 267
14. A.H. Rezvani, D.P. Caldwell, and E.D. Levin Nicotine-serotonergic drug interactions and attentional performance in rats Psychopharmacology 179 2005 521 528
15. S. Ruotsalainen, J. Sirvio, P. Jakala, T. Puumala, E. MacDonald, and P. Riekkinen Sr. Differential effects of three 5-HT receptor antagonists on the performance of rats in attentional and working memory tasks Eur Neuropsychopharmacol 7 1997 99 108
16. E. Sanders-Bush, and S.E. Mayer 5-hydroxytryptamine (serotonin): receptor agonists and antagonists J.G. Hardman L. Limbird A.G. Goodman Gilman Goodman and Gilman's the pharmacological basis of therapeutics 10th edition 2001 McGraw-Hill New York 269 290
17. T. Sumiyoshi, H. Kido, H. Sakamoto, K. Urasaki, K. Suzuki, and N. Yamaguchi Time course of dopamine-D2 and serotonin-5-HT2 receptor occupancy rates by haloperidol and clozapine in vivo Jpn J Psychiatry Neurol 47 1993 131 137
18. M. Wagner, B.B. Quednow, J. Westheide, T.E. Schlaepfer, W. Maier, and K.U. Kuhn Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs. amisulpride Neuropsychopharmacology 30 2005 381 390
19. D.R. Weinberger, and B. Gallhofer Cognitive function in schizophrenia Int Clin Psychopharmacol 4 12 Suppl 1997 S29 S36
20. H.K. White, and E.D. Levin Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease Psychopharmacology 143 1999 158 165
21. S. Wonnacott, J. Irons, C. Rapier, B. Thorne, and G.G. Lunt Presynaptic modulation of transmitter release by nicotinic receptors A. Nordberg K. Fuxe B. Holmstedt A. Sundwall Progress in brain research 1989 Elsevier Science Publishers B.V. 157 163